The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors
Open accessAbstract
BACKGROUND: Evidence documents successful hepatitis C virus (HCV) treatment outcomes for people who inject drugs (PWID) and interest in HCV treatment among this population. Maximising HCV treatment for PWID can be an effective HCV preventative measure. Yet HCV treatment among PWID remains suboptimal. This review seeks to map social factors mediating HCV treatment access. METHOD: We undertook a review of the social science and public health literature pertaining to HCV treatment for PWID, with a focus on barriers to treatment access, uptake and completion. Medline and Scopus databases were searched, supplemented by manual and grey literature searches. A two step search was taken, with the first step pertaining to literature on HCV treatment for PWID and the second focusing on social structural factors. In total, 596 references were screened, with 165 articles and reports selected to inform the review. RESULTS: Clinical and individual level barriers to HCV treatment among PWID are well evidenced. These include patient and provider concerns regarding co-morbidities, adherence, and side effect management. Social factors affecting treatment access are less well evidenced. In attempting to map these, key barriers fall into the following domains: social stigma, housing, criminalisation, health care systems, and gender. Key facilitating factors to treatment access include: combination intervention approaches encompassing social as well as biomedical interventions, low threshold access to opiate substitution therapy, and integrated delivery of multidisciplinary care. CONCLUSION: Combination intervention approaches need to encompass social interventions in relation to housing, stigma reduction and systemic changes in policy and health care delivery. Future research needs to better delineate social factors affecting treatment access.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,267
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
Arora, S., Thornton, K., Murata, G., Deming, P., Kalishman, S., Dion, D., Parish, B., Burke, T., Pak, W., Dunkelberg, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009370 · Cited by 1,076
Risk environments and drug harms: a social science for harm reduction approach
Rhodes, T. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2008.10.003 · Cited by 948 · cited 2×
“Treatment access, as with patterns of health behaviour more broadly, can therefore be seen as a product of individual and environment interactions [30].”
BackgroundMethodSelf-citationHIV and risk environment for injecting drug users: the past, present, and future
Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60743-x · Cited by 559
Self-citationNeuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Dieperink, E., Willenbring, M., & Ho, S. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.867 · Cited by 422
Wolfe, D., Carrieri, M. P., & Shepard, D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60832-x · Cited by 418
Limited Uptake of Hepatitis C Treatment Among Injection Drug Users
Mehta, S. H., Genberg, B. L., Astemborski, J., Kavasery, R., Kirk, G. D., Vlahov, D., Strathdee, S. A., & Thomas, D. L. (2008) · Journal of Community Health · doi:10.1007/s10900-007-9083-3 · Cited by 327
The Everyday Violence of Hepatitis C among Young Women Who Inject Drugs in San Francisco
Bourgois, P., Prince, B., & Moss, A. (2004) · Human Organization · doi:10.17730/humo.63.3.h1phxbhrb7m4mlv0 · Cited by 318
Hagan, H., Pouget, E. R., & Des Jarlais, D. C. (2011) · Journal of Infectious Diseases · doi:10.1093/infdis/jir196 · Cited by 313
Cited by
Lewer, D., Freer, J., King, E., Larney, S., Degenhardt, L., Tweed, E. J., Hope, V. D., Harris, M., Millar, T., Hayward, A., et al. (2020) · Addiction · doi:10.1111/add.14892 · Cited by 161
Self-citationSmith, D. J., Combellick, J., Jordan, A. E., & Hagan, H. (2015) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.07.004 · Cited by 104
Harris, M., Rhodes, T., & Martin, A. (2013) · Social Science & Medicine · doi:10.1016/j.socscimed.2013.01.031 · Cited by 77
Self-citationDoran, J., Harris, M., Hope, V. D., Wright, T., Edmundson, C., Sinka, K., & Heinsbroek, E. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108080 · Cited by 37
Self-citationBrothers, T. D., Lewer, D., Bonn, M., Webster, D., & Harris, M. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049924 · Cited by 16
Self-citation
Metadata
- Authors
- Harris, M., & Rhodes, T.
- Venue
- Harm Reduction Journal
- Published
- 2013
- Volume
- 10
- Issue
- 1
- Pages
- 7
- ISSN
- 1477-7517 (ISSN-L)
- OpenAlex
- W2142011497
- Cited by
- 260
- References
- 98
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. https://app.cochat.ai/papers/10.1186/1477-7517-10-7
- The paper
- Harris, M., & Rhodes, T. (2013). Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduction Journal. https://doi.org/10.1186/1477-7517-10-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.